Back
Alibaba Health Information Technology 10K Form
Buy
60
ALBBY
Alibaba Health Information Technology
Last Price:
7.89
Seasonality Move:
-7.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALBBY News And Ratings
See the #1 stock for the next 7 days that we like better than ALBBY
ALBBY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.91B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 63.02 |
| Annual Sales: | $3.26 |
| Price / Book: | 2.95 |
Profitability
| EPS (TTM): | 0.17100 |
|---|---|
| Net Income (TTM): | $115.85M |
| Gross Margin: | $832.75M |
| Return on Equity: | 5.35% |
| Return on Assets: | 3.95% |
Alibaba Health Information Technology Earnings Forecast
Key Alibaba Health Information Technology Financial Ratios
- The Gross Profit Margin over the past 20 years for ALBBY is 21.30%.
- The Selling, General & Administrative Expenses for ALBBY have been equal to 8.03% of Gross Profit Margin.
- The Research & Development expenses have been 2.53% of Revenue.
- The Interest Expense is 1.09% of Operating Income.
- The Net Earning history of ALBBY is 1.99% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 11 years.
Alibaba Health Information Technology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Consumer Staples Distribution & Retail |
| Sector: | Consumer Staples |
| Current Symbol: | ALBBY |
| Website: | alihealth.cn |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.01 |
| Quick Ratio: | 2.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 70.31 |
|---|---|
| Forward P/E Ratio: | 0 |
ALBBY Technical Analysis vs Fundamental Analysis
Buy
60
Alibaba Health Information Technology (ALBBY)
is a Buy
Is Alibaba Health Information Technology a Buy or a Sell?
-
Alibaba Health Information Technology stock is rated a Buy
The current Alibaba Health Information Technology [ALBBY] share price is $8.09. The Score for ALBBY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.